JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1981) 89, 355-363    DOI: 10.1677/joe.0.0890355
© 1981 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RIEUTORT, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by RIEUTORT, M.

ONTOGENETIC DEVELOPMENT OF THE INHIBITION OF GROWTH HORMONE RELEASE BY SOMATOSTATIN IN THE RAT: IN-VIVO AND IN-VITRO (PERIFUSION) STUDY

MICHEL RIEUTORT

An in-vitro study of GH secretion by rat fetal and neonatal pituitary glands was conducted using a perifusion system. After a 2 h period the GH content of the effluent was constant. Theophylline, thyrotrophin releasing hormone (TRH) and rat stalk median eminence extract (SME) were effective stimuli of GH release from the pituitary glands of the 19·5-day-old fetuses. Somatostatin, added to the medium (10 µg/ml), had no inhibitory effect on GH release (basal or stimulated by either theophylline or SME) before day 4 after birth. After postnatal day 5, somatostatin always inhibited GH secretion. These findings were consistent with the results of experiments in vivo. In rats tested within 4 days of birth, sodium pentobarbitone-stimulated plasma GH levels were not reduced by somatostatin; on day 4 and thereafter somatostatin depressed the response to pentobarbitone injection.

These results indicate a postnatal maturation of the regulation of GH release by the hypothalamo–hypophysial system in the rat.




This article has been cited by other articles:


Home page
EndocrinologyHome page
G. Diaz-Torga, C. Feierstein, C. Libertun, D. Gelman, M. A. Kelly, M. J. Low, M. Rubinstein, and D. Becu-Villalobos
Disruption of the D2 Dopamine Receptor Alters GH and IGF-I Secretion and Causes Dwarfism in Male Mice
Endocrinology, April 1, 2002; 143(4): 1270 - 1279.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. K. Reed, A. I. Korytko, R. W. Hipkin, W. B. Wehrenberg, A. Schonbrunn, and L. Cuttler
Pituitary Somatostatin Receptor (sst)1-5 Expression during Rat Development: Age-Dependent Expression of sst2
Endocrinology, October 1, 1999; 140(10): 4739 - 4744.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
E. E. Muller, V. Locatelli, and D. Cocchi
Neuroendocrine Control of Growth Hormone Secretion
Physiol Rev, April 1, 1999; 79(2): 511 - 607.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. X. Simonian, H. E. Murray, G. E. Gillies, and A. E. Herbison
Estrogen-Dependent Ontogeny of Sex Differences in Somatostatin Neurons of the Hypothalamic Periventricular Nucleus
Endocrinology, March 1, 1998; 139(3): 1420 - 1428.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the Society for Endocrinology.